Duobrii

Active Ingredient(s): Halobetasol Propionate + Tazarotene
FDA Approved: * April 25, 2019
Pharm Company: * BAUSCH HEALTH AMERICAS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Duobrii Overview

Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid.[1][2] It is primarily used for the treatment of plaque psoriasis and acne.[3] Tazarotene is also used as a therapeutic for photoaged and photodamaged skin.[3] Tazarotene is a member of the acetylenic class of retinoids.[3] Contents 1 Medical uses 1.1 Pregnancy 2 Contraindications 3 Adverse effects...

Read more Duobrii Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene

Recent Duobrii Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Halobetasol Propionate + Tazarotene
  • Lotion: 0.01% + 0.045%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Duobrii: (1 result)

Sorted by National Drug Code
  • 0187-0653 Duobrii Topical Lotion by Valeant Pharmaceuticals North America LLC

Drugs with one or more similar ingredients: (5 results)